We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Serono, CancerVax Terminate Development of Cancer Drug
Serono, CancerVax Terminate Development of Cancer Drug
October 7, 2005
Serono and its development partner CancerVax have halted clinical trials and development of an experimental melanoma drug after an independent review found the drug was likely no more effective than a placebo.